We are live on ! Find out more
LKFT

Lakefront Biotherapeutics American Depositary Shares
LKFT

69 hedge funds and large institutions have $1.03B invested in Lakefront Biotherapeutics American Depositary Shares in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 20 increasing their positions, 29 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $922M → $1.03B (+$105M)

3.86% less ownership

Funds ownership: 23.69% → 19.83% (-3.9%)

10% less call options, than puts

Call options by funds: $849K | Put options by funds: $947K

12% less funds holding

Funds holding: 78 → 69 (-9)

31% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 29

39% less first-time investments, than exits

New positions opened: 11 | Existing positions closed: 18

67% less funds holding in top 10

Funds holding in top 10: 3 → 1 (-2)

Holders
69
Holders Change
-9
Holders Change %
-11.54%
% of All Funds
1.72%
Holding in Top 10
1
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-66.67%
% of All Funds
0.02%
New
11
Increased
20
Reduced
29
Closed
18
Calls
$849K
Puts
$947K
Net Calls
-$98K
Net Calls Change
+$317K

Top Buyers

Rank Fund Capital Flow
1
O
OrbiMed
New York
+$21M
2
FCM
Farallon Capital Management
California
+$20.6M
3
OMC
Old Mission Capital
Illinois
+$3.35M
4
JP Morgan Chase
JP Morgan Chase
New York
+$2.62M
5
ACM
Atika Capital Management
New York
+$2.45M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$66.1M
2
EC
EcoR1 Capital
California
-$29.5M
3
CAM
Cormorant Asset Management
Massachusetts
-$22.9M
4
Renaissance Technologies
Renaissance Technologies
New York
-$17.4M
5
Sands Capital Management
Sands Capital Management
Virginia
-$8.95M
Name Holding Trade Value Shares
Change 		Change in
Stake
CPC
51
Cookson Peirce & Co
Pennsylvania
$356K +$39.3K +450 +15%
LCM
52
Landscape Capital Management
New Jersey
$330K -$292K -3,342 -51%
WAM
53
World Asset Management
Michigan
$304K -$699 -8 -0.3%
AI
54
Atria Investments
North Carolina
$298K +$256K +2,933 New
AG
55
Advisor Group
Arizona
$288K -$22.8K -261 -8%
Bank of Montreal
56
Bank of Montreal
Ontario, Canada
$288K – – –
BAM
57
Belpointe Asset Management
Nevada
$281K +$241K +2,762 New
Comerica Bank
58
Comerica Bank
Texas
$265K – – –
DTL
59
Dynamic Technology Lab
Singapore
$218K +$187K +2,144 New
Envestnet Asset Management
60
Envestnet Asset Management
Illinois
$177K +$92.9K +1,063 +157%
UBS Group
61
UBS Group
Switzerland
$117K -$107K -1,227 -52%
AP
62
Advisors Preferred
Maryland
$105K +$89.9K +1,029 New
Wells Fargo
63
Wells Fargo
California
$75K +$44.5K +509 +226%
CG
64
Cutler Group
California
$61K -$238K -2,719 -82%
QT
65
Quantbot Technologies
New York
$15K +$12.9K +148 New
Royal Bank of Canada
66
Royal Bank of Canada
Ontario, Canada
$5K -$360K -4,120 -99%
OAM
67
Oppenheimer Asset Management
New York
$5K +$524 +6 +13%
TRCT
68
Tower Research Capital (TRC)
New York
$2K +$1.75K +20 New
CAM
69
Cormorant Asset Management
Massachusetts
– -$22.9M -300,000 Closed
AC
70
Ascend Capital
California
– -$5.66M -73,964 Closed
GAMA
71
Graticule Asia Macro Advisors
New York
– -$3.2M -41,818 Closed
Millennium Management
72
Millennium Management
New York
– -$3.17M -41,458 Closed
Hudson Bay Capital Management
73
Hudson Bay Capital Management
Connecticut
– -$1.53M -20,000 Closed
WMSA
74
Weiss Multi-Strategy Advisers
New York
– -$1.53M -20,000 Closed
Northern Trust
75
Northern Trust
Illinois
– -$1.41M -18,480 Closed
1 2
3
4

LKFT Hedge Fund Activity: Q3 2017 in Review

69 of the 4,012 institutional investors tracked by Wall St. Rank reported a position in Lakefront Biotherapeutics American Depositary Shares (LKFT) for Q3 2017, worth a combined $1.03B — up 11% from $922M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of LKFT and 11 opened new positions — a net loss of 7 holders — while 29 trimmed existing stakes and 20 added.

The largest buyer was OrbiMed, adding an estimated $21M. The largest seller was Fidelity Investments, cutting an estimated $66.1M.

  • 69 institutional investors held Lakefront Biotherapeutics American Depositary Shares (LKFT) as of Q3 2017, down from 78 in Q2 2017.
  • Funds reported $1.03B of Lakefront Biotherapeutics American Depositary Shares stock for Q3 2017, up 11% quarter-over-quarter.
  • 11 funds opened new Lakefront Biotherapeutics American Depositary Shares positions in Q3 2017 and 18 closed out, a net change of -7 holders.
  • The largest Lakefront Biotherapeutics American Depositary Shares buyer in Q3 2017 was OrbiMed, an estimated $21M added.
  • The largest Lakefront Biotherapeutics American Depositary Shares seller in Q3 2017 was Fidelity Investments, an estimated $66.1M sold.

Based on aggregated 13F filings for Q3 2017.